中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共5条，第1-5条

帮助

条数/页：排序方式：
	New advances in drug development for metabolic dysfunction-associated diseases and alcohol-associated liver disease 期刊论文 OAI收割 CELL AND BIOSCIENCE, 2024, 卷号: 14, 期号: 1, 页码: 18 作者: Zhang, Jinming; Li, Yixin; Yang, Liu; Ma, Ningning; Qian, Shengying \| 收藏 \| 浏览/下载：5/0 \| 提交时间：2024/08/22 MASLD ALD T2DM Metabolic disorder Drug candidate
	Improved synthesis of YT-14, a potent antibiotic to multidrug-resistant strains 期刊论文 OAI收割 JOURNAL OF CHEMICAL RESEARCH, 2018, 期号: 7, 页码: 354-360 作者: Wei, Jianhai; Kong, Deyu; Wang, Lei; Zhang, Yinyong; Hu, Wenhao \| 收藏 \| 浏览/下载：42/0 \| 提交时间：2019/01/08 drug candidate YT-14 multidrug resistant Gram-negative bacteria
	Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation 期刊论文 OAI收割 ACS INFECTIOUS DISEASES, 2017, 卷号: 3, 期号: 3, 页码: 199-205 作者: Lu, Dong; Liu, Feifei; Xing, Weiqiang; Tong, Xiankun; Wang, Lang \| 收藏 \| 浏览/下载：43/0 \| 提交时间：2019/01/08 pyridazinone HBV DNA-free capsids drug-like optimization SAR study lead candidate
	Polymorphism of the 5R-5-hydroxytriptolide 期刊论文 OAI收割 Acta Pharmaceutica Sinica, 2011, 卷号: 46, 期号: 11, 页码: 1357-1360 作者: Liu Ruili; Yang Yaxi; Chen Dongying \| 收藏 \| 浏览/下载：28/0 \| 提交时间：2019/01/08 5R-5-hydroxytriptolide crystalline polymorph preparation crystalline polymorph characterization drug candidate stability
	sulfatedpolymannuroguluronateinhibitstatinducedslkcelladhesionviaanovelbindingsiteakkrspatialtriad 期刊论文 OAI收割 actapharmacologicasinica, 2011, 卷号: 32, 期号: 5, 页码: 647 作者: Wu Yanlin; Ai Jing; Zhao Jingming; Xiong Bing; Xin Xiaojie \| 收藏 \| 浏览/下载：20/0 \| 提交时间：2020/07/01 HIV-1 TAT PROTEIN INTERACTIONS HEPARAN-SULFATE KAPOSIS-SARCOMA DRUG CANDIDATE GROWTH-FACTOR DOMAIN OLIGOSACCHARIDES MULTIPLE SIZE sulfated polymannuroguluronate transactivating factor of the HIV-1 virus (Tat) binding site Kaposi's sarcoma heparin mutation HIV-1